13, August 2013

UPDATE: Cancer Programme IPP-204106

ImmuPharma plc (LSE:IMM) ("Immupharma" or the "Company" or the "Group"), the specialist drug discovery and development company is pleased to provide an update on its lead cancer programme IPP-204106.As...

Click here for more details

12, August 2013

FDA Grants ImmuPharma ammended SPA for Lupuzor Phase III; Company Progresses Development Activities

 ImmuPharma plc (LSE:IMM) (“ImmuPharma” or the “Company” or the “Group”), the specialist drug discovery and development company, is delighted to announce that following its discussions with t...

Click here for more details

08, July 2013

Appointment of Scientific Advisory Board

ImmuPharma plc (LSE:IMM) (“ImmuPharma” or the “Company” or the “Group”), the specialist drug discovery and development company, is delighted to announce that it has appointed some of the world&rsq...

Click here for more details

21, May 2013

ImmuPharma secures £50M financing facility for Lupuzor Phase III

Facility Underwritten by Henderson Global's Subsidary Darwin StrategicImmuPharma plc (LSE:IMM) (“ImmuPharma” or the “Company” or the “Group”), the specialist drug discovery and development com...

Click here for more details

08, April 2013

Immupharma gets Lupuzor research boost

Immupharma's (LON:IMM) new lupus treatment Lupuzor has the potential to offer substantial benefits to patients compared with current market leader Benlysta, new research has suggested.A survey of US and European rheumatologists...

Click here for more details

28, February 2013

ImmuPharma Commences Trading on the Stuttgart Stock Exchange

ImmuPharma PLC (LSE: IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, is pleased to announces that it has been informed by Baader Bank AG that its shares are now being...

Click here for more details

28, January 2013

CNRS Confirms Lupuzor’sTM Effectiveness

ImmuPharma PLC (LSE: IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, is pleased to announce that its key scientific collaboration partner and the inventor of ImmuPhar...

Click here for more details